BIOTRONIK opens new Asia-Pacific hub in Singapore

BIOTRONIK announced today the opening of its new Asia Pacific Manufacturing and Research Hub. The 20,000 m² site will serve as the company’s central hub in Asia-Pacific, with hundreds of employees working in manufacturing, quality, research & development (R&D), and sales and marketing.

BIOTRONIK, founded in Berlin, Germany, in 1963 is a pioneer in implantable pacemakers, defibrillators, and vascular intervention for 60 years. BIOTRONIK’s presence in Singapore began in 2012, and in 2016, the company inaugurated its first manufacturing site, complementing its high-quality manufacturing sites in Germany, Switzerland and the United States. Now in 2023, the new facility has been designed with an emphasis on workspace agility for modern, optimized collaboration. The new site includes several spacious cleanrooms and laboratories developing and manufacturing state-of-the art Cardiac Rhythm Management (CRM) devices.

Singapore is well known for its highly skilled professionals, efficient infrastructure, and healthy business environment. With the new hub, the company underlines its commitment to Singapore and Asia-Pacific.